Filing Details
- Accession Number:
- 0001209191-17-059331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-03 19:30:58
- Reporting Period:
- 2017-11-02
- Accepted Time:
- 2017-11-03 19:30:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594864 | Juno Therapeutics Inc. | JUNO | Biological Products, (No Disgnostic Substances) (2836) | 463656275 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1656998 | Robert Azelby | C/O 400 Dexter Avenue North Suite 1200 Seattle WA 98109 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-02 | 6,666 | $25.29 | 79,998 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-02 | 6,666 | $54.95 | 73,332 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-11-02 | 6,666 | $0.00 | 6,666 | $25.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,334 | 2026-11-07 | No | 4 | M | Direct |
Footnotes
- The sales and related option exercises reported on this Form 4 were executed pursuant to a trading plan adopted by the reporting person on March 20, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- 1/48th of the shares subject to the option became vested and exercisable on December 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter.
Billionaire Hedge Funds
